These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2401536)

  • 1. Circulating cortisol & related steroids following ketoconazole challenge in Cushing's disease.
    Dash RJ; Khandekar S; Lata V; Bhansali A
    Indian J Med Res; 1990 Jun; 92():167-8. PubMed ID: 2401536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole in the treatment of Cushing's disease.
    Dash RJ; Khandekar S; Lata V; Bhansali A
    J Assoc Physicians India; 1990 Jul; 38(7):486-9. PubMed ID: 2292555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid synthesis inhibition by ketoconazole: sites of action.
    Trachtenberg J; Zadra J
    Clin Invest Med; 1988 Feb; 11(1):1-5. PubMed ID: 2966691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoconazole blocks cortisol secretion in man by inhibition of adrenal 11 beta-hydroxylase.
    Engelhardt D; Dörr G; Jaspers C; Knorr D
    Klin Wochenschr; 1985 Jul; 63(13):607-12. PubMed ID: 2993735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of plasma adrenal steroids to synthetic ACTH under ketoconazole in man.
    Yamakita N; Yasuda K; Murase H; Murayama M; Goshima E; Hirai M; Noritake N; Takeda N; Miura K
    Endocrinol Jpn; 1987 Feb; 34(1):29-35. PubMed ID: 3038504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma.
    Levine AC; Mitty HA; Gabrilove JL
    J Urol; 1988 Jul; 140(1):11-5. PubMed ID: 2967899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of inhibition of human adrenal steroidogenesis by ketoconazole.
    Couch RM; Muller J; Perry YS; Winter JS
    J Clin Endocrinol Metab; 1987 Sep; 65(3):551-4. PubMed ID: 3497939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin inhibits adrenal 17,20-lyase activity in man.
    Nestler JE; McClanahan MA; Clore JN; Blackard WG
    J Clin Endocrinol Metab; 1992 Feb; 74(2):362-7. PubMed ID: 1730815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketoconazole inhibition of the bifunctional cytochrome P450c17 does not affect androgen formation from the endogenous lyase substrate. The catalytic site remains refractory in the course of intermediary hydroxyprogesterone processing.
    Kühn-Velten WN; Lessmann M
    Biochem Pharmacol; 1992 Dec; 44(12):2371-8. PubMed ID: 1472102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D; Weber MM
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis.
    Weber MM; Lang J; Abedinpour F; Zeilberger K; Adelmann B; Engelhardt D
    Clin Investig; 1993 Nov; 71(11):933-8. PubMed ID: 8312688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells.
    Lamberts SW; Bons EG; Bruining HA; de Jong FH
    J Pharmacol Exp Ther; 1987 Jan; 240(1):259-64. PubMed ID: 3027305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects of o,p'-DDD on human adrenal steroid synthesis].
    Ojima M; Saito M; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1984 Jul; 60(7):852-71. PubMed ID: 6094274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site of action of low dose ketoconazole on androgen biosynthesis in men.
    Santen RJ; Van den Bossche H; Symoens J; Brugmans J; DeCoster R
    J Clin Endocrinol Metab; 1983 Oct; 57(4):732-6. PubMed ID: 6309882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ketoconazole on human ovarian C17,20-desmolase and aromatase.
    Weber MM; Will A; Adelmann B; Engelhardt D
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):213-8. PubMed ID: 2004042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prismatic cases: 17,20-desmolase (17,20-lyase) deficiency.
    Zachmann M
    J Clin Endocrinol Metab; 1996 Feb; 81(2):457-9. PubMed ID: 8636249
    [No Abstract]   [Full Text] [Related]  

  • 17. Progesterone 16 alpha-hydroxylase activity is catalyzed by human cytochrome P450 17 alpha-hydroxylase.
    Swart P; Swart AC; Waterman MR; Estabrook RW; Mason JI
    J Clin Endocrinol Metab; 1993 Jul; 77(1):98-102. PubMed ID: 8325965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ketoconazole in the treatment of Cushing's syndrome.
    Loli P; Berselli ME; Tagliaferri M
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketoconazole and plasma and urine steroid levels in Cushing's disease.
    Mortimer RH; Cannell GR; Thew CM; Galligan JP
    Clin Exp Pharmacol Physiol; 1991 Aug; 18(8):563-9. PubMed ID: 1655322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and long-term tolerance of ketoconazole in the treatment of Cushing's disease].
    Tabarin A; Navarranne A; Corcuff B; Guerin J; Kern AM; Roger P
    Ann Endocrinol (Paris); 1990; 51(1):27-32. PubMed ID: 2171415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.